Inducible degradation is a powerful approach for identifying the function of a specific protein or protein complex. Recently, a plant auxin-inducible degron (AID) system has been shown to degrade AID-tagged target proteins in nonplant cells. Here, we demonstrate that an AID-tagged protein can functionally replace an endogenous protein depleted by RNAi, leading to an inducible null phenotype rapidly after auxin addition. The AID system is shown to be capable of controlling the stability of AID-tagged proteins that are in either nuclear or cytoplasmic compartments and even when incorporated into protein complexes. Induced degradation occurs rapidly after addition of auxin with protein half-life reduced to as little as 9 min and proceeding to completion with firstorder kinetics. AID-mediated instability is demonstrated to be rapidly reversible. Induced degradation is shown to initiate and continue in all cell cycle phases, including mitosis, making this system especially useful for identifying the function(s) of proteins of interest during specific points in the mammalian cell cycle.
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proteasome | SCF | ubiquitin C onditional inactivation or depletion of proteins is a powerful method for determining gene function and central to our understanding of complex biological systems. Protein expression is frequently controlled at the DNA level by disruption of the coding sequence of the gene (1) or at the level of the mRNA by using methodologies for suppressing mRNA accumulation, especially with RNAi (2, 3) . However, in both cases, protein depletion is indirect and the rapidity of loss is dependent on the stability of the protein, resulting in very slow loss for long-lived proteins. This serves as a major limitation for all but the shortest lived proteins, because different severities of phenotypes are typically observed at differing levels of depletion, especially in the case of proteins that have multiple functions (4) . Additionally, neither gene inactivation nor RNAi silencing is readily reversible (in the latter case, this is an obligate consequence of the relatively long half-life of guide RNAs once incorporated into the RNAi-induced silencing complex) (5) . RNAi-mediated mRNA degradation often also suffers from incomplete silencing and/or off-target effects.
To overcome these limitations, a variety of systems have been developed that allow the posttranslational degradation of proteins using cell-permeable small molecules (4, (6) (7) (8) (9) (10) . Recently, a system for inducible-protein depletion was developed that relies on the transplantation of a ligand-induced degradation system found in plants (4) . All eukaryotes possess Skp1, Cullin, and F-Box protein (SCF) ubiquitin ligases, which are composed of three core subunits and a variable F-box that is responsible for substrate recruitment to the SCF complex (11, 12) (Fig. 1A) . F-box proteins associate with the SCF complex through an interaction of their F-box domain with the Skp1 protein (13) . In plants, auxin hormones promote the interaction between the F-box protein TIR1 and proteins containing an auxin-inducible degron (AID) (14) (15) (16) . Orthologs of TIR1 and AID are only found in plant species; however, due to the high degree of conservation of Skp1 in eukaryotes, ectopically expressed TIR1 can associate with Skp1 in animal cells and form an SCF TIR1 complex (Fig. 1B) . SCF TIR1 has been demonstrated to promote auxin-inducible degradation of proteins tagged with an AID in a variety of animal cells (4, 8) (Fig. 1B) , including inducible degradation of a nuclear localized GFP in human cells. However, not yet established is whether auxin-inducible degradation of AID-tagged proteins is (i) active against a diverse array of both nuclear and cytoplasmic substrates, (ii) capable of controlling the stability of substrates incorporated in macromolecular complexes, (iii) sufficiently robust to achieve rapid and complete degradation of all target proteins, (iv) initiated and continuously active in all phases of the cell cycle, and (v) rapidly reversible within minutes of auxin removal. Here, we provide a detailed characterization of the AID system in human cells (4, 8) . We demonstrate that the AID system possesses all five of these properties, and thus represents a powerful tool for studying protein function in mammalian cells.
Results

AID System Allows Protein Degradation in Both Transformed and
Nontransformed Human Cells. We used retroviral transduction to construct a monoclonal colorectal cancer cell line (DLD-1) and a diploid nontumor cell line (RPE-1) stably expressing TIR1-9xMyc. Stable expression of TIR1-9xMyc with or without 3 d of incubation with 500 μM auxin hormone indole-3-acetic acid (IAA) did not affect growth or cell cycle distribution of either cell type (Fig. 1C) , consistent with an earlier report in chicken DT40 cells (4) . To test if rapid proteolysis of substrates could be induced by addition of auxin, TIR1-9Myc expressing DLD-1 and RPE-1 cells was cotransfected with mRFP-tagged histone H2B (H2B mRFP ) and AID-YFP-tagged histone H2B (H2B AID-YFP ; the AID tag is 228 aa or ∼25 kDa). In the absence of IAA, histone H2B mRFP and histone H2B AID-YFP accumulated in the nucleus of both cell lines (Fig. 1D) . However, addition of IAA led to degradation of histone H2B AID-YFP but not histone H2B mRFP , demonstrating that the AID system can be used for induced proteolysis of target proteins in both transformed and nontransformed human cells (Fig. 1D ). All additional experiments were performed using TIR1-9Myc expressing DLD-1 cells.
AID System Can Quantitatively Degrade Divergent Protein Substrates in Human Cells. To determine whether rapid, auxin-induced degradation was a general property of AID-tagged protein substrates, five different transgenes encoding carboxy-terminally AID-YFPtagged substrates were integrated at the same genomic locus of DLD-1 TIR1-9Myc cells using Flp-mediated recombination (17) . Two of these transgenes encoded cytosolic proteins: polo-kinase 4 (Plk4), which regulates centriole duplication (18) (19) (20) , and cyclin B1, the regulatory subunit of the cyclin-dependent kinase Cdk1 (21) . In addition, we analyzed three nuclear proteins: histone H2B, a subunit of the nucleosome; centromere protein A (CENP-A), the centromere-specific histone H3 variant that assembles into centromeric chromatin (22) ; and Telomeric Repeat-Binding Factor 2 (TRF2), a component of the shelterin complex required for the protection of telomere ends (23, 24) .
Transgene expression was under doxycycline control, and following induction, all five substrates localized as expected: Plk4 AID-YFP localized at the centrosome, cyclin B1 AID-YFP localized diffusely in the cytoplasm, histone H2B AID-YFP localized within the nucleus, CENP-A AID-YFP localized to centromeres, and TRF2
AID-YFP associated with telomeres ( Fig. 2A) . Purifications using the GFP-binder protein demonstrated that all substrates were incorporated into protein complexes, with histone H2B AID-YFP and CENP-A AID-YFP both associating with endogenous histone H2B and histone H3, Plk4
AID-YFP binding to CEP152, TRF2 AID-YFP associating with POT1, and cyclin B1 AID-YFP binding to Cdk1 (Fig. 2B ). All five proteins were quantitatively destroyed within 24 h of addition of auxin, as seen with immunoblotting ( Fig.  3A ) and quantitative immunofluorescence (Fig. 3B ).
Auxin-Induced Degradation Reduces Protein t 1/2 to <20 Min. The rapidity of induced degradation of each of the five differentially localized substrates incorporated into different protein complexes was quantified with fluorescence time-lapse microscopy after addition of IAA. Substrate degradation began rapidly after the addition of IAA and proceeded with first-order kinetics (Fig.  4) , and histone H2B AID-YFP within individual cells of a randomly cycling population. Similar kinetics were found in all cells within each population ( Fig. S3 and Movies S1, S2, S3, S4, and S5). Because these cells were distributed in G1, S, and G2 phases of the cell cycle in relative abundances of ∼5:2:1 [based on FACS profiles (Fig. S4 ) and the typical length of each portion of the cycle (26) ], auxin-induced degradation of substrates must be able to initiate and proceed in all three portions of the interphase cell cycle.
To test whether substrate degradation could be initiated during mitosis, histone H2B AID-YFP -expressing cells were arrested in mitosis by treatment for 6 h with the microtubule assembly poison nocodazole. Following addition of IAA, histone H2B AID-YFP degradation occurred rapidly with kinetics similar to those observed in interphase cells (t 1/2 = 50 min in interphase vs. t 1/2 = 60 min in mitosis; Fig. 5B and Movie S6), demonstrating that induced degradation is almost as efficient in mitosis as it is in the other three cell cycle phases.
AID-Mediated Protein Degradation Is Quickly Reversible, Enabling
Inducible Protein Expression in Human Cells. To determine the reversibility of AID-targeted degradation after removal of IAA, we first examined the localization of TIR1-9xMyc in cells expressing Plk4 AID-YFP . Within 20 min of IAA addition, TIR1-9xMyc became enriched at the centrosome, colocalizing with the substrate Plk4 AID-YFP (Fig. 6A ). This recruitment of TIR1-9xMyc to the centrosome was reversible; 2 h after IAA washout, TIR-9xMyc localized diffusely in the nucleus/cytoplasm and was undetectable at the centrosome (Fig. 6A) , consistent with rapid reversibility of AID-targeted degradation.
To establish the kinetics with which AID-tagged target proteins reaccumulate after removal of IAA, cells were treated with IAA for 2 h to degrade Plk4 AID-YFP quantitatively (>99%); IAA was then removed, and quantitative time-lapse fluorescence microscopy was used to follow Plk4 AID-YFP reaccumulation. Newly made Plk4 AID-YFP was detectable almost immediately after IAA washout (within <10 min), and Plk4 AID-YFP protein levels increased linearly for 200 min, reaching steady state by ∼350 min after IAA removal ( Fig. 6B and Movie S7).
The rapid reversibility of the AID system raised the possibility that it could be exploited to achieve inducible protein expression. To monitor the incorporation of newly synthesized CENP-A in living cells, we treated cells expressing CENP-A AID-YFP with IAA for 2 h to degrade previously synthesized CENP-A AID-YFP , removed the IAA, and followed cells by time-lapse fluorescence microscopy. Newly synthesized CENP-A AID-YFP accumulated diffusely in the nuclei of interphase cells; however, consistent with our previous report (25) , it incorporated into centromeres soon after cells exited mitosis and entered G1 phase (Fig. 6C and Movie S8). This demonstrates that the rapid reversibility of the AID system is useful for providing inducible control of protein expression in human cells.
Functional Replacement of BubR1 with an AID-Tagged BubR1 Transgene
Allows Temporal Control of Mitotic Checkpoint Activity. The mitotic checkpoint is an essential cell cycle control mechanism that operates during every division to prevent the irreversible transition into anaphase until all chromosomes attach to microtubules of the mitotic spindle (27) . BubR1 is an essential component of the mitotic checkpoint, but previous studies of the protein's function have relied on strategies that chronically deplete BubR1 levels over multiple cell cycles (28, 29) . To establish if the AID system can be used to achieve the rapid, functional inactivation of BubR1, we established a method to replace endogenous BubR1 protein with an AID-tagged version capable of rapid, inducible destruction.
Endogenous BubR1 was depleted by >90% in cells using siRNA targeting the 3′ UTR of the BubR1 mRNA and was replaced by expression of siRNA-resistant, amino-terminally GFP-AID-tagged BubR1 ( GFP-AID BubR1) encoded by a transgene containing a distinct 3′ UTR (Fig. 7 A and B) . Cells were treated with nocodazole to block spindle microtubule assembly, thereby chronically activating the mitotic checkpoint. The duration of the mitotic arrest was then determined by time-lapse microscopy. As expected, suppression of endogenous BubR1 resulted in premature mitotic exit in the presence of nocodazole, and this was rescued by expression of GFP-AID BubR1: ∼80% of BubR1-depleted cells exited mitosis in 200 min compared with <10% of the cells expressing GFP-AID BubR1 (Fig. 7C, sets I and II) . Addition of IAA for 4 h before mitotic entry led to the complete destruction of GFP-AID BubR1 (Fig. 7 A and B , set III) and a rapid mitotic exit in the presence of nocodazole (Fig.  7C, set III) . Surprisingly, following destruction of GFP-AID BubR1, cells exited mitosis even more rapidly than cells depleted of endogenous BubR1 (Fig. 7C, compare sets II and III) . A likely explanation for this effect is that cells displaying the most complete depletion of BubR1 will undergo catastrophic mitotic divisions and/ or cease cycling during the 48-h period required for the siRNAmediated reduction in endogenous BubR1. By contrast, functional complementation with GFP-AID BubR1 allows cells to survive complete loss of endogenous BubR1. Therefore, following destruction of GFP-AID BubR1, these cells will more rapidly exit mitosis than cells only partially depleted in endogenous BubR1. Thus, rapid depletion of BubR1 using the AID system can produce a more complete null phenotype than is achieved by depletion of the BubR1 mRNA.
Discussion
Systems that permit the posttranslational regulation of protein stability with small molecules are valuable tools for interrogating biological systems. Here, we have provided an extensive characterization of the auxin-inducible degradation system in human cells and demonstrated that this system (i) is active against multiple substrates, (ii) is capable of targeting degradation of both nuclear and cytoplasmic substrates that are monomeric or in macromolecular complexes, (iii) proceeds rapidly and to completion with a diverse array of substrates, (iv) is active in all phases of the cell cycle, (v) is rapidly reversible within minutes of auxin removal, and (vi) is able to be used in combination with a functional replacement of an endogenous gene. For all five substrates we tested using the AID system, protein degradation proceeded to completion and occurred rapidly, with a t 1/2 as short as 9 min and with an average time of 19 min. The time required for depletion of >90% of the substrate ranged between 30 and 120 min (Figs. 4 and 5) . The speed and level to which substrates are depleted from cells make the AID system an ideal choice for studying phenotypes resulting from acute loss of protein function.
The AID system offers a method to overcome limitations of previous approaches (e.g., siRNA) in which gradual depletion of a protein may produce a different phenotype compared with when a protein is rapidly removed from cells (4) . Indeed, different phenotypes may be observed at differing levels of protein depletion; thus, to determine the true "null' phenotype, the protein in question should be rapidly and completely depleted from cells. This caveat is especially relevant when examining long-lived proteins (e.g., CENP-A), which may require days to be fully depleted from cells (25, 30, 31) .
A remarkable feature of the AID system is its ability to destroy substrates that are incorporated into large protein complexes, such as TRF2 AID-YFP (part of the six-subunit shelterin complex) and CENP-A AID-YFP and Histone H2B AID-YFP (components of the eight-subunit nucleosome complex) (Fig. 2 B and C) . This feature makes the AID system suitable for the analysis of singleprotein components of multisubunit complexes. It was notable that the AID system promoted the depletion of chromatinbound TRF2
AID-YFP , CENP-A AID-YFP , and histone H2B AID-YFP , as well as cytosolic components, such as Plk4 AID-YFP and cyclin B1 AID-YFP (Fig. 3) , indicating that proteins localized to many different regions of the cell will be susceptible to AID-mediated degradation.
Our evidence that the AID system is capable of destroying substrates at all phases of the cell cycle demonstrates that SCF TIR1 is active throughout the cell cycle, with the recruitment of SCF TIR1 to the substrate being a rate-limiting step for proteolysis. The ability to destroy substrates at all stages of the cell cycle forms a major advantage for studying cell cycle-regulated processes and, to our knowledge, has not been demonstrated with any other system that allows regulation of protein stability with small molecules.
A final feature of the auxin-mediated degradation system is that it is rapidly reversible because new protein begins accumulating almost immediately after IAA removal (Fig. 6) . Protein accumulation after removal of auxin does not require transcription, and is thus faster than would occur following activation of an inducible promoter (e.g., doxycycline-inducible promoters). The extensive depletion of target proteins with the AID system raises the possibility that this technology may be useful (either alone or in combination with inducible promoters) in temporally regulating the induction of toxic genes.
Like other methods for posttranslational regulation of protein stability (4, 6-10), the auxin system does not control stability of endogenous, untagged proteins. Nevertheless, advances in the use of adeno associated viruses (32), zinc finger (33), and transcription activator-like effector endonucleases (34) open the possibility of carrying out homologous recombination in somatic human cells to create endogenous proteins fused to the AID. A second possibility is to deplete an endogenous protein using siRNA or gene-targeting technologies and reconstitute cells with an siRNA-resistant, AIDtagged transgene, as we have done for the mitotic checkpoint protein BubR1 (35) (Fig. 7) . Third, a dominantly acting gene product can be tagged with the AID and rapidly removed from cells.
Finally, an interesting extension of this work will be to determine whether the AID system will also prove to be useful for modulating the expression levels of proteins in animals. This could be particularly valuable in genetically engineered mouse models of human disease, where the AID system can be used to provide validation of potential therapeutic targets in an animal before specific inhibitors are available for use. [A potential caveat, however, is whether IAA can be administered at levels sufficient to induce protein degradation in animals without causing significant adverse toxicity (36, 37) .] Further studies will be required to address the applicability of the AID system in animals.
Materials and Methods
Constructs. The osTIR1-9Myc and AID ORF was a kind gift from Masato Kanemaki (National Institute of Genetics, Mishima, Japan). Full-length ORFs were cloned into a pcDNA5/FRT/TO-based vector (Invitrogen) modified to contain an amino-terminus or carboxy-terminus AID and a YFP tag.
Cell Biology and Generation of Stable Cell Lines. Cell culture and flow cytometry were performed as previously described (38) . osTIR1-9Myc was introduced into Flp-In TRex-DLD-1 parental cells or into RPE1 cells using retroviral delivery as described previously (39) . Stable integrates were selected in 2 μg/mL (DLD-1) or 5 μg/mL (RPE1) puromycin, and single clones were isolated using single-cell sorting (FACS-Vantage; Becton Dickinson). Stable, isogenic cell lines expressing AID-tagged transgenes were generated using FRT/Flp-mediated recombination, as described previously (40) . Expression of the AID-tagged transgenes was induced with 1 μg/mL doxycycline (SIGMA) for 8-24 h. Flp-In TRex-DLD-1, TIR1-9Myc cells were used for all the experiments, except for the experiments in Fig. 1 C and D , where RPE1 TIR1-9Myc cells were also used. Cell transfection was performed using FuGENE (Invitrogen). Small molecules were used at the following final concentrations: IAA, 500 μM (I5148; SIGMA); nocodazole, 2 μg/mL (SIGMA); MG132, 20 μM (Calbiochem); and cycloheximide, 50 μg/mL (SIGMA). siRNA directed against the 3′ UTR of BubR1 (5′-CUGUAUGUGCUGUAAUUUA-3′) was purchased from Thermo Fisher Scientific. Cells were transfected with 100 nM oligonucleotides using Oligofectamine (Invitrogen). Twenty-four hours after transfection, tetracycline was added to express GFP-AID-BubR1 for another 24 h before collecting cells for immunoblotting or analysis by time-lapse microscopy.
Protein Purification and Western Blotting. To purify AID-YFP-tagged transgenes, cells were lysed in lysis buffer [10 mM Tris (pH 7.5); 0.1% Triton X-100; 100 mM NaCl; 1 mM EDTA; 1 mM EGTA; 50 mM NaF; 20 mM β-glycerophosphate; 0.1 mM DTT; 200 nM microcystin; 1 mM PMSF; and 1 μM leupeptin, pepstatin, and chymostatin] and sonicated, and soluble extracts were prepared. The supernatant was incubated with beads alone or beads coupled to GFP binding protein (41) . Beads were washed five times in lysis buffer, and protein complexes were analyzed by immunoblotting. For immunoblot analysis, the following antibodies were used: BubR1 (rabbit, 1:5,000 covance), Mad2 (rabbit, 1:1,000; Bethyl Laboratories), DM1A (mouse anti-α-tubulin, 1:5,000), YFP (mouse anti-GFP, 1:500; Roche), POT1 (rabbit, 1:1,000; Abcam), Cep152 (rabbit, 1:1,000; Bethyl Laboratories), CDK1 (mouse, 1:500; Santa Cruz Biotechnology), Histone H3 (rabbit, 1:5,000; SIGMA), and Histone H2B (mouse, 1:1,000; Upstate Biotechnology). Immunofluorescence. Immunofluorescence was performed as previously described (42) using the following antibodies: 4A6 (mouse anti-Myc, 1:1,000; Upstate Biotechnology), TRF1 (rabbit, 1:1,000; a kind gift from Titia De Lange, The Rockefeller University, New York, NY), CENP-B (rabbit, 1:1,000; Abcam), Cyclin B1 (mouse, SC-245, 1:50; Santa Cruz Biotechnology), and SPD2-Cy3 (rabbit, 1:1,500; a kind gift from Karen Oegema, Ludwig Institute for Cancer Research, University of California at San Diego). YFP was visualized directly using a GFP filter set. Immunofluorescence images were collected using a Deltavision Core system (Applied Precision) controlling an interline CCD camera (Cooldsnap; Raper). Images were collected using a 100× 1.4-N.A. or 60× 1.4-N. A. oil objective at 0.2-μM z sections and subsequently deconvolved. Maximum intensity 2D projections were assembled for each image using softWoRx (Applied Precision). For quantification of YFP signal intensity, undeconvolved 2D maximum intensity projections were saved as unscaled 16-bit tagged image file format (TIFF) images and signal intensities were determined using MetaMorph (Molecular Devices). For Plk4 AID-YFP , a 20 × 20 pixel box and a larger 25 × 25 pixel box were drawn around the centrosome (marked with γ-tubulin staining). Integrated YFP intensity in the smaller box was calculated by subtracting the mean fluorescence intensity in the area between the two boxes (mean background) from the mean YFP intensity in the smaller box and multiplying by the area of the smaller box. For CENP-A AID-YFP , a 15 × 15 pixel circle was drawn around a centromere (marked by CENP-B staining) and an identical circle was drawn adjacent to the structure (background). The integrated signal intensity of each individual centromere was calculated by subtracting the fluorescence intensity of the background from the intensity of the adjacent centromere. Approximately 25 centromeres were averaged to provide the average fluorescence intensity for each individual cell. The signal intensity of TRF2 AID-YFP was determined using an identical method, except TRF1 staining was used to determine the localization of the telomere.
To determine Histone H2B AID-YFP intensity, a 50 × 50 pixel box was drawn in the nucleus or in the cytoplasm (background) and the integrated signal intensity of each cell was calculated by subtracting the fluorescence intensity of the background from the intensity of the nucleus. An identical procedure was used to calculate the intensity of Cyclin B1 AID-YFP , except background readings from the nucleus were subtracted from the cytoplasmic signal.
Live Cell Microscopy. Cells were seeded into 35-mm, poly-L-lysine-coated, glassbottomed culture dishes (MatTek) and transferred to CO 2 independent media supplemented with doxycycline 24 h later. Cells were maintained at 37°C in an environmental control station, and images were collected using a Deltavision RT system (Applied Precision) with a 40× 1.35-N.A. oil lens at 3-or 5-min time intervals. IAA was added at the microscope stage. For each time point, 4 × 3-μM z sections were acquired for YFP, and maximum intensity projections were created using softWoRx. Movies were assembled and analyzed using MetaMorph software (Molecular Devices). For quantification of YFP signal intensity, undeconvolved 2D maximum intensity projections were saved as unscaled 16-bit TIFF images and signal intensity was determined for each frame of the movie using MetaMorph. The procedure for quantifying the levels of Plk4 , a circle 10 pixels in diameter was drawn around an individual centromere (centromeric pool) and an identical circle was drawn adjacent to the structure (diffuse pool). The integrated signal intensity for six cells was averaged to provide the average fluorescence intensity at each time point.
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